Renibus

Renibus is a biotech company in Southlake, United States, founded in 2015. It has raised $108.4M across 3 rounds, most recently a $72.0M Series B in September 2023.

Prevent. Protect. Improve.

Headquarters
Southlake, Texas
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$108.4M
Last Round
$72.0M Series BSep 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

Renibus Therapeutics is a clinical-stage biopharmaceutical company dedicated to treating, improving, and extending patients' lives by developing breakthrough products to improve outcomes associated with renal, metabolic, and cardiac diseases. Founded in 2015 and headquartered in Southlake, Texas, Renibus is advancing two late-stage programs: Veverimer, a non-absorbed polymer in Phase 3 development for adults with chronic kidney disease and metabolic acidosis; and RBT-1, which recently completed the PROTECT Phase 3 trial for cardiac and renal protection in surgical settings. The company's leadership team brings extensive pharmaceutical commercialization experience, including prior successes at ZS Pharma (acquired by AstraZeneca for $2.7 billion), Adams Respiratory Therapeutics (acquired by Reckitt Benckiser for $2.3 billion), and multiple other biopharmaceutical ventures.

Summary

It lists 11–50 employees. It has raised $108.4M in total across 3 rounds, most recently a $72.0M Series B round in Sep 2023.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BSep 2023
$72.0M

Sign up to see all 3 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Renibus on Indexed.vc
<a href="https://indexed.vc/companies/renibus"><img src="https://indexed.vc/api/badge/company/renibus" alt="Renibus on Indexed.vc" width="260" height="76" /></a>